Propanc Biopharma, Inc. (PPCB)
0.4635
-0.04
(-7.06%)
USD |
NASDAQ |
Oct 08, 16:00
0.4635
0.00 (0.00%)
After-Hours: 20:00
Propanc Biopharma Net Income (Quarterly) : -4.573M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.573M |
| March 31, 2026 | -6.360M |
| December 31, 2025 | -3.091M |
| September 30, 2025 | -4.838M |
| June 30, 2025 | -4.072M |
| March 31, 2025 | -54.07M |
| December 31, 2024 | -0.4302M |
| September 30, 2024 | -0.3543M |
| June 30, 2024 | -0.3586M |
| March 31, 2024 | -0.5267M |
| December 31, 2023 | -0.5844M |
| September 30, 2023 | -0.3509M |
| June 30, 2023 | -0.748M |
| March 31, 2023 | -0.8098M |
| December 31, 2022 | -0.4854M |
| September 30, 2022 | -0.6173M |
| June 30, 2022 | -0.9048M |
| March 31, 2022 | -0.4627M |
| December 31, 2021 | -0.80M |
| September 30, 2021 | -0.4907M |
| June 30, 2021 | -0.779M |
| March 31, 2021 | -0.4177M |
| December 31, 2020 | -0.4036M |
| September 30, 2020 | -0.4255M |
| June 30, 2020 | 1.204M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.586M |
| December 31, 2019 | -1.867M |
| September 30, 2019 | -1.492M |
| June 30, 2019 | -1.602M |
| March 31, 2019 | -0.5819M |
| December 31, 2018 | -1.45M |
| September 30, 2018 | -2.125M |
| June 30, 2018 | -1.422M |
| March 31, 2018 | -1.491M |
| December 31, 2017 | -2.202M |
| September 30, 2017 | -1.924M |
| June 30, 2017 | -1.634M |
| March 31, 2017 | -1.371M |
| December 31, 2016 | -3.761M |
| September 30, 2016 | -1.102M |
| June 30, 2016 | -2.858M |
| March 31, 2016 | -2.152M |
| December 31, 2015 | -3.562M |
| September 30, 2015 | -0.8389M |
| June 30, 2015 | -1.827M |
| March 31, 2015 | -0.4542M |
| December 31, 2014 | -0.3455M |
| September 30, 2014 | -0.7833M |
| June 30, 2014 | -0.2176M |
| March 31, 2014 | -0.0669M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 4.573M |
| EPS Diluted (Quarterly) | -1.381 |
| Enterprise Value | 1.328M |
| Earnings Yield | -5.57K% |
| Normalized Earnings Yield | -5766.41 |